23 Jul, 2026
According to Straits Research, the global pediatric neurology device market size was valued at $3.11 billion in 2025 and is projected to grow from $3.33 billion in 2026 to $5.67 billion by 2034, registering a CAGR of 6.9% during the forecast period 2026–2034.
Pediatric neurology is a specialized field of medicine that focuses on diagnosing and treating neurological disorders in neonates, infants, children, and adolescents. Child neurology encompasses diseases and disorders affecting the spinal cord, brain, peripheral nervous system (PNS), autonomic nervous system (ANS), musculature, and blood vessels in children and adolescents. A child neurologist, also known as a pediatric neurologist, is a medical professional specializing in diagnosing and treating neurological disorders in children and adolescents.
Neurological disorders (NDs) are diseases that affect the autonomic, peripheral, and central nervous systems of the body. According to a new United Nations report, neurological disorders such as Alzheimer's and Parkinson's disease, strokes, multiple sclerosis, and epilepsy, as well as migraines, brain injuries, and neuro infections, affect up to one billion people, or roughly one-sixth of the world's population, with approximately 6.8 million dying each year. Similarly, according to global statistics, 24 million people have Alzheimer's and other dementias, 62 million have cerebrovascular disease, 326 million have migraines, and 50 million have epilepsy. These factors propel the global market.
The advancement of secure and effective therapies for pediatric neurological disorders contributes to improved efficacy in patient care. Continuous progress in the development of diagnostic technologies and instruments is imperative. The implementation of rigorous research methodologies and the development of advanced protocols are essential to provide superior and beneficial solutions.
Several novel technologies have emerged in the field of neurology, including a handheld vagus nerve stimulator designed specifically for episodic cluster headaches, an FDA-approved test for genetic health risks, a neurosurgery tracking system, a transcranial magnetic stimulation (TMS) therapy system for the treatment of depression, and a rehabilitation assistance robot catering to patients with stroke and other neurological conditions.
North America is the most significant global pediatric neurology device market shareholder and is predicted to grow significantly during the forecast period. The United States is predicted to account for a sizeable portion due to factors like the rising prevalence of neurological disorders and the country's aging population. The major reason fueling the market's expansion is the rising prevalence of neurological disorders like epilepsy, Parkinson's disease, Alzheimer's disease, and neuromuscular disorders. According to the Pan American Health Organization, neurological diseases are to blame for 533,172 deaths in the region in 2019, of which 213,129 (40%) were caused by men and 320,043 (60%) by women. Similarly, age-standardized mortality rates were 32.9 per 100,000 people, with 33.1 deaths per 100,000 for males and 32.2 for women.
sales@straitsresearch.com